Selected research
Market Structure
Global Benidipine Hydrochloride Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Benidipine Hydrochloride Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Benidipine Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Benidipine Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Benidipine Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Benidipine Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Benidipine Hydrochloride Tablets include CSPC Pharmaceutical Group, Livzon Pharmaceutical Group, Tanabe Mitsubishi Pharma Corporation, Yangtze River Pharmaceutical Group, Chengdu Better Pharmaceutical, Qilu Pharmaceutical, Shenzhen Salubris Pharmaceuticals and Kyowa Kirin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Benidipine Hydrochloride Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Benidipine Hydrochloride Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Benidipine Hydrochloride Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Benidipine Hydrochloride Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Benidipine Hydrochloride Tablets Segment by Company
CSPC Pharmaceutical Group
Livzon Pharmaceutical Group
Tanabe Mitsubishi Pharma Corporation
Yangtze River Pharmaceutical Group
Chengdu Better Pharmaceutical
Qilu Pharmaceutical
Shenzhen Salubris Pharmaceuticals
Kyowa Kirin
Benidipine Hydrochloride Tablets Segment by Type
4mg
8mg
Benidipine Hydrochloride Tablets Segment by Application
Clinic
Hospital
Others
Benidipine Hydrochloride Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Benidipine Hydrochloride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Benidipine Hydrochloride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Benidipine Hydrochloride Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Benidipine Hydrochloride Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Benidipine Hydrochloride Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Benidipine Hydrochloride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Benidipine Hydrochloride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 4mg
- 8mg
Applications
- Clinic
- Hospital
- Others
Companies covered
- CSPC Pharmaceutical Group
- Livzon Pharmaceutical Group
- Tanabe Mitsubishi Pharma Corporation
- Yangtze River Pharmaceutical Group
- Chengdu Better Pharmaceutical
- Qilu Pharmaceutical
- Shenzhen Salubris Pharmaceuticals
- Kyowa Kirin
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Benidipine Hydrochloride Tablets Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Benidipine Hydrochloride Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Benidipine Hydrochloride Tablets Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Benidipine Hydrochloride Tablets Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Benidipine Hydrochloride Tablets Market Dynamics
- 2.1 Benidipine Hydrochloride Tablets Industry Trends
- 2.2 Benidipine Hydrochloride Tablets Industry Drivers
- 2.3 Benidipine Hydrochloride Tablets Industry Opportunities and Challenges
- 2.4 Benidipine Hydrochloride Tablets Industry Restraints
3 Benidipine Hydrochloride Tablets Market by Manufacturers
- 3.1 Global Benidipine Hydrochloride Tablets Revenue by Manufacturers (2021-2026)
- 3.2 Global Benidipine Hydrochloride Tablets Sales by Manufacturers (2021-2026)
- 3.3 Global Benidipine Hydrochloride Tablets Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Benidipine Hydrochloride Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Benidipine Hydrochloride Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Benidipine Hydrochloride Tablets Manufacturers, Product Type & Application
- 3.7 Global Benidipine Hydrochloride Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Benidipine Hydrochloride Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Benidipine Hydrochloride Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Benidipine Hydrochloride Tablets Tier 1, Tier 2, and Tier 3
4 Benidipine Hydrochloride Tablets Market by Type
- 4.1 Benidipine Hydrochloride Tablets Type Introduction
- 4.1.1 4mg
- 4.1.2 8mg
- 4.2 Global Benidipine Hydrochloride Tablets Sales by Type
- 4.2.1 Global Benidipine Hydrochloride Tablets Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Benidipine Hydrochloride Tablets Sales by Type (2021-2032)
- 4.2.3 Global Benidipine Hydrochloride Tablets Sales Market Share by Type (2021-2032)
- 4.3 Global Benidipine Hydrochloride Tablets Revenue by Type
- 4.3.1 Global Benidipine Hydrochloride Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Benidipine Hydrochloride Tablets Revenue by Type (2021-2032)
- 4.3.3 Global Benidipine Hydrochloride Tablets Revenue Market Share by Type (2021-2032)
5 Benidipine Hydrochloride Tablets Market by Application
- 5.1 Benidipine Hydrochloride Tablets Application Introduction
- 5.1.1 Clinic
- 5.1.2 Hospital
- 5.1.3 Others
- 5.2 Global Benidipine Hydrochloride Tablets Sales by Application
- 5.2.1 Global Benidipine Hydrochloride Tablets Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Benidipine Hydrochloride Tablets Sales by Application (2021-2032)
- 5.2.3 Global Benidipine Hydrochloride Tablets Sales Market Share by Application (2021-2032)
- 5.3 Global Benidipine Hydrochloride Tablets Revenue by Application
- 5.3.1 Global Benidipine Hydrochloride Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Benidipine Hydrochloride Tablets Revenue by Application (2021-2032)
- 5.3.3 Global Benidipine Hydrochloride Tablets Revenue Market Share by Application (2021-2032)
6 Global Benidipine Hydrochloride Tablets Sales by Region
- 6.1 Global Benidipine Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Benidipine Hydrochloride Tablets Sales by Region (2021-2032)
- 6.2.1 Global Benidipine Hydrochloride Tablets Sales by Region (2021-2026)
- 6.2.2 Global Benidipine Hydrochloride Tablets Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Benidipine Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Benidipine Hydrochloride Tablets Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Benidipine Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Benidipine Hydrochloride Tablets Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Benidipine Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Benidipine Hydrochloride Tablets Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Benidipine Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Benidipine Hydrochloride Tablets Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Benidipine Hydrochloride Tablets Revenue by Region
- 7.1 Global Benidipine Hydrochloride Tablets Revenue by Region
- 7.1.1 Global Benidipine Hydrochloride Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Benidipine Hydrochloride Tablets Revenue by Region (2021-2026)
- 7.1.3 Global Benidipine Hydrochloride Tablets Revenue by Region (2027-2032)
- 7.1.4 Global Benidipine Hydrochloride Tablets Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Benidipine Hydrochloride Tablets Revenue (2021-2032)
- 7.2.2 North America Benidipine Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Benidipine Hydrochloride Tablets Revenue (2021-2032)
- 7.3.2 Europe Benidipine Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Benidipine Hydrochloride Tablets Revenue (2021-2032)
- 7.4.2 Asia-Pacific Benidipine Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Benidipine Hydrochloride Tablets Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Benidipine Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 CSPC Pharmaceutical Group
- 8.1.1 CSPC Pharmaceutical Group Company Information
- 8.1.2 CSPC Pharmaceutical Group Business Overview
- 8.1.3 CSPC Pharmaceutical Group Benidipine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 CSPC Pharmaceutical Group Benidipine Hydrochloride Tablets Product Portfolio
- 8.1.5 CSPC Pharmaceutical Group Recent Developments
- 8.2 Livzon Pharmaceutical Group
- 8.2.1 Livzon Pharmaceutical Group Company Information
- 8.2.2 Livzon Pharmaceutical Group Business Overview
- 8.2.3 Livzon Pharmaceutical Group Benidipine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Livzon Pharmaceutical Group Benidipine Hydrochloride Tablets Product Portfolio
- 8.2.5 Livzon Pharmaceutical Group Recent Developments
- 8.3 Tanabe Mitsubishi Pharma Corporation
- 8.3.1 Tanabe Mitsubishi Pharma Corporation Company Information
- 8.3.2 Tanabe Mitsubishi Pharma Corporation Business Overview
- 8.3.3 Tanabe Mitsubishi Pharma Corporation Benidipine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Tanabe Mitsubishi Pharma Corporation Benidipine Hydrochloride Tablets Product Portfolio
- 8.3.5 Tanabe Mitsubishi Pharma Corporation Recent Developments
- 8.4 Yangtze River Pharmaceutical Group
- 8.4.1 Yangtze River Pharmaceutical Group Company Information
- 8.4.2 Yangtze River Pharmaceutical Group Business Overview
- 8.4.3 Yangtze River Pharmaceutical Group Benidipine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Yangtze River Pharmaceutical Group Benidipine Hydrochloride Tablets Product Portfolio
- 8.4.5 Yangtze River Pharmaceutical Group Recent Developments
- 8.5 Chengdu Better Pharmaceutical
- 8.5.1 Chengdu Better Pharmaceutical Company Information
- 8.5.2 Chengdu Better Pharmaceutical Business Overview
- 8.5.3 Chengdu Better Pharmaceutical Benidipine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Chengdu Better Pharmaceutical Benidipine Hydrochloride Tablets Product Portfolio
- 8.5.5 Chengdu Better Pharmaceutical Recent Developments
- 8.6 Qilu Pharmaceutical
- 8.6.1 Qilu Pharmaceutical Company Information
- 8.6.2 Qilu Pharmaceutical Business Overview
- 8.6.3 Qilu Pharmaceutical Benidipine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Qilu Pharmaceutical Benidipine Hydrochloride Tablets Product Portfolio
- 8.6.5 Qilu Pharmaceutical Recent Developments
- 8.7 Shenzhen Salubris Pharmaceuticals
- 8.7.1 Shenzhen Salubris Pharmaceuticals Company Information
- 8.7.2 Shenzhen Salubris Pharmaceuticals Business Overview
- 8.7.3 Shenzhen Salubris Pharmaceuticals Benidipine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Shenzhen Salubris Pharmaceuticals Benidipine Hydrochloride Tablets Product Portfolio
- 8.7.5 Shenzhen Salubris Pharmaceuticals Recent Developments
- 8.8 Kyowa Kirin
- 8.8.1 Kyowa Kirin Company Information
- 8.8.2 Kyowa Kirin Business Overview
- 8.8.3 Kyowa Kirin Benidipine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Kyowa Kirin Benidipine Hydrochloride Tablets Product Portfolio
- 8.8.5 Kyowa Kirin Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Benidipine Hydrochloride Tablets Value Chain Analysis
- 9.1.1 Benidipine Hydrochloride Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Benidipine Hydrochloride Tablets Production Mode & Process
- 9.2 Benidipine Hydrochloride Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Benidipine Hydrochloride Tablets Distributors
- 9.2.3 Benidipine Hydrochloride Tablets Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst